RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..3 of 3 - per page
Order by
Seeking development opportunities with novel delivery technologies for oral, topical and transdermal products
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Generic molecules, OTC products and novel delivery technologies required for the Sub-Saharan African market.
Our client is a start up company that is looking for off patent generics indicated for oncology or respiratory disorders and innovative delivery platforms to which to incorporate them into. More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Generics Market Outlook: 2015
Oct 2010 - 112 pages - $7,600
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
World Market for Prescription Generic Drugs, 6th Edition
Apr 2008 - 250 pages - $3,995
Generics in Asia-Pacific
Sep 2011 - 39 pages - $250
Emerging Generic Drug Markets in Europe
Dec 2007 - 196 pages - $1,390
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Generics in Asia-Pacific
Sep 2010 - 37 pages - $250
Par Pharmaceutical Generics Company Intelligence Report
Jan 2011 - 20 pages - $340
Teva Pharmaceutical Industries Generics Company Intelligence Report
Jan 2011 - 54 pages - $340
Generics in Japan
Sep 2011 - 40 pages - $250
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Generics del
Therapeutic target
Central Nervous System del

Visit also genericlicensing.com

The website which helps the generic industry do business. Visit now

Browse By

Therapeutic target
Age-related disorders (other)
Amyotrophic lateral sclerosis
CNS (other)
Neurodegenerative disorders
Neurological
Pain
Psychiatric
Subarachnoid hemorrhage
Traumatic brain injury
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us